|
| | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024 SB0199 Introduced 1/31/2023, by Sen. Sara Feigenholtz SYNOPSIS AS INTRODUCED: |
| |
Amends the Nurse Practice Act. Removes a provision providing that the scope of practice of an advanced practice registered nurse with full practice authority includes prescribing benzodiazepines or Schedule II narcotic drugs.
|
| |
| | A BILL FOR |
|
|
| | SB0199 | | LRB103 25368 AMQ 51713 b |
|
|
1 | | AN ACT concerning regulation.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Nurse Practice Act is amended by changing |
5 | | Section 65-43 as follows: |
6 | | (225 ILCS 65/65-43) |
7 | | (Section scheduled to be repealed on January 1, 2028) |
8 | | Sec. 65-43. Full practice authority. |
9 | | (a) An Illinois-licensed advanced practice registered |
10 | | nurse certified as a nurse practitioner, nurse midwife, or |
11 | | clinical nurse specialist shall be deemed by law to possess |
12 | | the ability to practice without a written collaborative |
13 | | agreement as set forth in this Section. |
14 | | (b) An advanced practice registered nurse certified as a |
15 | | nurse midwife, clinical nurse specialist, or nurse |
16 | | practitioner who files with the Department a notarized |
17 | | attestation of completion of at least 250 hours of continuing |
18 | | education or training and at least 4,000 hours of clinical |
19 | | experience after first attaining national certification shall |
20 | | not require a written collaborative agreement. Documentation |
21 | | of successful completion shall be provided to the Department |
22 | | upon request. |
23 | | Continuing education or training hours required by |
|
| | SB0199 | - 2 - | LRB103 25368 AMQ 51713 b |
|
|
1 | | subsection (b) shall be in the advanced practice registered |
2 | | nurse's area of certification as set forth by Department rule. |
3 | | The clinical experience must be in the advanced practice |
4 | | registered nurse's area of certification. The clinical |
5 | | experience shall be in collaboration with a physician or |
6 | | physicians. Completion of the clinical experience must be |
7 | | attested to by the collaborating physician or physicians or |
8 | | employer and the advanced practice registered nurse. If the |
9 | | collaborating physician or physicians or employer is unable to |
10 | | attest to the completion of the clinical experience, the |
11 | | Department may accept other evidence of clinical experience as |
12 | | established by rule. |
13 | | (c) The scope of practice of an advanced practice |
14 | | registered nurse with full practice authority includes: |
15 | | (1) all matters included in subsection (c) of Section |
16 | | 65-30 of this Act; |
17 | | (2) practicing without a written collaborative |
18 | | agreement in all practice settings consistent with |
19 | | national certification; |
20 | | (3) authority to prescribe both legend drugs and |
21 | | Schedule II through V controlled substances; this |
22 | | authority includes prescription of, selection of, orders |
23 | | for, administration of, storage of, acceptance of samples |
24 | | of, and dispensing over the counter medications, legend |
25 | | drugs, and controlled substances categorized as any |
26 | | Schedule II through V controlled substances, as defined in |
|
| | SB0199 | - 3 - | LRB103 25368 AMQ 51713 b |
|
|
1 | | Article II of the Illinois Controlled Substances Act, and |
2 | | other preparations, including, but not limited to, |
3 | | botanical and herbal remedies; |
4 | | (4) (blank) prescribing benzodiazepines or Schedule II |
5 | | narcotic drugs, such as opioids, only in a consultation |
6 | | relationship with a physician; this consultation |
7 | | relationship shall be recorded in the Prescription |
8 | | Monitoring Program website, pursuant to Section 316 of the |
9 | | Illinois Controlled Substances Act, by the physician and |
10 | | advanced practice registered nurse with full practice |
11 | | authority and is not required to be filed with the |
12 | | Department; the specific Schedule II narcotic drug must be |
13 | | identified by either brand name or generic name; the |
14 | | specific Schedule II narcotic drug, such as an opioid, may |
15 | | be administered by oral dosage or topical or transdermal |
16 | | application; delivery by injection or other route of |
17 | | administration is not permitted; at least monthly, the |
18 | | advanced practice registered nurse and the physician must |
19 | | discuss the condition of any patients for whom a |
20 | | benzodiazepine or opioid is prescribed; nothing in this |
21 | | subsection shall be construed to require a prescription by |
22 | | an advanced practice registered nurse with full practice |
23 | | authority to require a physician name ; |
24 | | (5) authority to obtain an Illinois controlled |
25 | | substance license and a federal Drug Enforcement |
26 | | Administration number; and |
|
| | SB0199 | - 4 - | LRB103 25368 AMQ 51713 b |
|
|
1 | | (6) use of only local anesthetic. |
2 | | The scope of practice of an advanced practice registered |
3 | | nurse does not include operative surgery. Nothing in this |
4 | | Section shall be construed to preclude an advanced practice |
5 | | registered nurse from assisting in surgery. |
6 | | (d) The Department may adopt rules necessary to administer |
7 | | this Section, including, but not limited to, requiring the |
8 | | completion of forms and the payment of fees. |
9 | | (e) Nothing in this Act shall be construed to authorize an |
10 | | advanced practice registered nurse with full practice |
11 | | authority to provide health care services required by law or |
12 | | rule to be performed by a physician.
|
13 | | (Source: P.A. 101-13, eff. 6-12-19; 102-75, eff. 1-1-22 .)
|